MAP2K7 and cancer: Additionally, all components functioning upstream of Erks in the RTK-Ras-Raf-MEK pathway are mutated in cancer, and Erks have been shown to be required for tumor development, for example in a mouse model of non-small cell lung carcinoma [72].